AU6131999A - (staphylococcus aureus) genes and polypeptides - Google Patents
(staphylococcus aureus) genes and polypeptidesInfo
- Publication number
- AU6131999A AU6131999A AU61319/99A AU6131999A AU6131999A AU 6131999 A AU6131999 A AU 6131999A AU 61319/99 A AU61319/99 A AU 61319/99A AU 6131999 A AU6131999 A AU 6131999A AU 6131999 A AU6131999 A AU 6131999A
- Authority
- AU
- Australia
- Prior art keywords
- polypeptides
- genes
- staphylococcus aureus
- aureus
- staphylococcus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000191967 Staphylococcus aureus Species 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9896498P | 1998-09-01 | 1998-09-01 | |
US60098964 | 1998-09-01 | ||
PCT/US1999/019726 WO2000012678A2 (en) | 1998-09-01 | 1999-08-31 | Staphylococcus aureus genes and polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6131999A true AU6131999A (en) | 2000-03-21 |
Family
ID=22271760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU61319/99A Abandoned AU6131999A (en) | 1998-09-01 | 1999-08-31 | (staphylococcus aureus) genes and polypeptides |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1109911A4 (en) |
JP (1) | JP2002525083A (en) |
AU (1) | AU6131999A (en) |
CA (1) | CA2341311A1 (en) |
WO (1) | WO2000012678A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083924A (en) * | 1998-03-12 | 2000-07-04 | Smithkline Beecham Corporation | DnaB of staphylococcus aureus |
US6689595B1 (en) | 1999-08-04 | 2004-02-10 | Pharmacia & Upjohn Company | Crystallization and structure determination of Staphylococcus aureus thymidylate kinase |
WO2001011054A1 (en) | 1999-08-04 | 2001-02-15 | Pharmacia & Upjohn Company | CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STAPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) |
CA2378010A1 (en) * | 1999-08-04 | 2001-02-15 | Pharmacia & Upjohn Company | Crystallization and structure determination of staphylococcus aureus thymidylate kinase |
WO2001055443A1 (en) | 2000-01-31 | 2001-08-02 | Pharmacia & Upjohn Company | Crystallization and structure determination of staphylococcus aureus nad synthetase |
US6764823B2 (en) | 2000-04-06 | 2004-07-20 | Pharmacia & Upjohn Company | Antimicrobial methods and materials |
US6864080B2 (en) | 2000-06-30 | 2005-03-08 | Pharmacia & Upjohn Company | Crystallization and structure of Staphylococcus aureus peptide deformylase |
AU2003280250A1 (en) * | 2002-11-05 | 2004-06-07 | Affinium Pharmaceuticals, Inc. | Crystal structures of bacterial thymidylate kinases |
US20090317421A1 (en) * | 2006-01-18 | 2009-12-24 | Dominique Missiakas | Compositions and methods related to staphylococcal bacterium proteins |
US9181329B2 (en) | 2007-08-31 | 2015-11-10 | The University Of Chicago | Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions |
WO2009029831A1 (en) | 2007-08-31 | 2009-03-05 | University Of Chicago | Methods and compositions related to immunizing against staphylococcal lung diseases and conditions |
HUE057713T2 (en) | 2009-04-03 | 2022-05-28 | Univ Chicago | Compositions and methods related to protein a (spa) variants |
WO2012003474A2 (en) | 2010-07-02 | 2012-01-05 | The University Of Chicago | Compositions and methods related to protein a (spa) variants |
US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1094396A (en) * | 1996-06-06 | 1998-04-14 | Smithkline Beecham Corp | Method for obtaining nucleotide sequence using randomly primed amplification |
EP0826774B1 (en) * | 1996-08-28 | 2006-02-08 | Affinium Pharmaceuticals, Inc. | Staphylococcal Fab I enoyl-ACP reductase |
US5827689A (en) * | 1996-11-13 | 1998-10-27 | Smithkline Beecham Corporation | FabD polynucleotides |
US6682919B1 (en) * | 1997-11-14 | 2004-01-27 | Smithkline Beecham Corporation | FabH |
US6083924A (en) * | 1998-03-12 | 2000-07-04 | Smithkline Beecham Corporation | DnaB of staphylococcus aureus |
-
1999
- 1999-08-31 EP EP99948076A patent/EP1109911A4/en not_active Withdrawn
- 1999-08-31 WO PCT/US1999/019726 patent/WO2000012678A2/en not_active Application Discontinuation
- 1999-08-31 JP JP2000571068A patent/JP2002525083A/en not_active Withdrawn
- 1999-08-31 CA CA002341311A patent/CA2341311A1/en not_active Abandoned
- 1999-08-31 AU AU61319/99A patent/AU6131999A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2341311A1 (en) | 2000-03-09 |
EP1109911A4 (en) | 2005-04-27 |
WO2000012678A3 (en) | 2000-06-15 |
WO2000012678A2 (en) | 2000-03-09 |
JP2002525083A (en) | 2002-08-13 |
EP1109911A2 (en) | 2001-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5636498A (en) | Pesticide composition | |
AU4710900A (en) | Sample evaporative control | |
AU4782099A (en) | Herbicides | |
AU1537699A (en) | Extracellular matrix-binding proteins from (staphylococcus aureus) | |
AU4167699A (en) | Antimicrobial agents | |
AU5972598A (en) | Pesticide compositions | |
AU3108399A (en) | (staphylococcus aureus) genes and polypeptides | |
EP1233974A4 (en) | 37 staphylococcus aureus genes and polypeptides | |
AU6131999A (en) | (staphylococcus aureus) genes and polypeptides | |
AU4776899A (en) | Herbicide | |
AU3687297A (en) | Insecticidal composition | |
AU7495298A (en) | Watering can | |
AU2579797A (en) | Antimicrobial agent | |
AU7053798A (en) | Synergetic fungicide composition | |
AU3940697A (en) | Pesticides | |
AU4064699A (en) | Insecticide | |
AU7527898A (en) | Herbicide | |
AU5903398A (en) | Staphylococcus aureus histidine protein kinase essential genes | |
AUPP617598A0 (en) | Genetic sequence and uses therefor | |
AUPO060996A0 (en) | Sexing gene | |
AU2174599A (en) | Hair manipulation | |
AU5582799A (en) | Staphylococcus aureus polypeptides | |
AU6811698A (en) | Pesticides | |
AU8105398A (en) | Fungicide mixtures | |
AU8576998A (en) | Antibacterial composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |